Watch as Aetion’s scientific and regulatory leaders explored FDA's evolving approach to RWE and tools you can use to generate regulatory-grade evidence.
Clarify FDA’s RWE strategy
Discuss high-level implications of recent
draft guidances, including required actions
Describe draft guidance alignment with existing scientific methodologies and tools